The first stop for professional medicines advice

Training and Development

77 results

Applied filters

Using the Medication Safety Update effectively

15 December 2022Effective use provides assurance that an organisation is aware of the most critical medication safety related information, and acts on this to improve safety

Promoting medication incident reporting

15 December 2022Increased medication incident reporting provides greater opportunities for learning and improving medication safety

Conducting a medication incident investigation

15 December 2022Practical guidance to support those undertaking medication incident investigations

Resources to support learning from medication incidents and harms

15 December 2022Organisations should utilise resources to effectively drive improvement based on the learning from incidents, concerns, disputes and claims

Practice support for the Medication Safety Officer (MSO)

15 December 2022An infrastructure of support opportunities exists that MSOs should utilise to deliver their role most effectively

The Medication Safety Officer (MSO) role

15 December 2022Understanding the role and responsibilities of the MSO in practice will assist organisations in delivering their medication safety agenda

Information resources for managing medicines in renal impairment

14 December 2022SPS and other information resources can help healthcare professionals provide advice on medicines in renal impairment.

Heart failure management in frail older people

2 December 2022Guidance to help upskill primary and secondary care clinicians in decision making when managing heart failure in frail older people

Atrial fibrillation management in frail older people

2 December 2022Guidance to help upskill primary and secondary care clinicians in decision making when managing atrial fibrillation in frail older people

Managing cardiovascular disease in frail older people

2 December 2022A pragmatic approach for managing common cardiovascular long-term conditions in older people living with frailty, multimorbidity and polypharmacy